Login

Keith Byrne, Ellex Medical Lasers Ltd 00:00:00

Share On Facebook Share On Twitter

Ellex Medical Lasers - a South Australian Health-tech company

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Bond Market Turmoil: Understanding the Recent Challenges and Future Strategies | Sébastien Page, CIO , T. Rowe Price.
00:10:00
Mike Palmer, CFP® on the Value of Wealth Management Advice
00:00:00
Trained as a psychiatrist / David Shumway Jones, Ph.D., M.D. A. Bernard Ackerman Professor of the Culture of Medicine, HMS
00:10:00
Navigating a Bear Market: Insights from Allodium Investment Consultants
00:10:00
Jim Greig: Representative of Metals Group Inc. | Jim Greig, CEO of Metals Group Inc.
00:10:00
Weijian Shan on Asia Investments and the Impact of US-China Relations | Weijian Shan, CEO, PAG.
00:10:00
Top 5 Questions on the Minds of Women Investors Today | Susan Olson - Financial Advisor of Abacus Wealth Partners
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
"Navigating Market Volatility: Javid Mirza's Insights on Economic Challenges and Portfolio Strategies at Canaccord Genuity"
00:10:00
Sberbank's Pandemic Impact and Future Outlook | Philippe Brassac, CEO, Crédit Agricole SA.
00:10:00
Interview with Don Ranta, CEO of Rare Element Resources on Rare Earth Market Trends and Company Prospects
00:10:00
New Year Market Volatility: Understanding the Causes and What to Do About It | Ben Smith, Founder, Cove Financial Planning.

© 2026 Nehu